Adverse events96

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

61 to 80 of 96

Type	Event	Organ system	Group	Affected	At risk	Events
serious	Acute respiratory Failure	Respiratory, thoracic and mediastinal disorders	Sarizotan Low Dose	0	33
serious	Acute respiratory Failure	Respiratory, thoracic and mediastinal disorders	Sarizotan High Dose	1	56	1
serious	Acute respiratory Failure	Respiratory, thoracic and mediastinal disorders	Placebo	0	39
serious	Asthma	Respiratory, thoracic and mediastinal disorders	Sarizotan Low Dose	0	33
serious	Asthma	Respiratory, thoracic and mediastinal disorders	Sarizotan High Dose	1	56	1
serious	Asthma	Respiratory, thoracic and mediastinal disorders	Placebo	0	39
serious	Somnolence	Nervous system disorders	Sarizotan Low Dose	0	33
serious	Somnolence	Nervous system disorders	Sarizotan High Dose	2	56	2
serious	Somnolence	Nervous system disorders	Placebo	1	39	1
serious	Change in seizure presentation	Nervous system disorders	Sarizotan Low Dose	0	33
serious	Change in seizure presentation	Nervous system disorders	Sarizotan High Dose	1	56	1
serious	Change in seizure presentation	Nervous system disorders	Placebo	0	39
serious	Generalised tonic-clonic seizure	Nervous system disorders	Sarizotan Low Dose	0	33
serious	Generalised tonic-clonic seizure	Nervous system disorders	Sarizotan High Dose	1	56	1
serious	Generalised tonic-clonic seizure	Nervous system disorders	Placebo	0	39
serious	Constipation	Gastrointestinal disorders	Sarizotan Low Dose	0	33
serious	Constipation	Gastrointestinal disorders	Sarizotan High Dose	1	56	1
serious	Constipation	Gastrointestinal disorders	Placebo	0	39
serious	Hyponatraemia	Metabolism and nutrition disorders	Sarizotan Low Dose	0	33
serious	Hyponatraemia	Metabolism and nutrition disorders	Sarizotan High Dose	1	56	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous page Next page

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02790034/events?page=4

API reference For AI assistants